THEMIS2抗体THEMIS2兔多抗抗体Thymocyte
-expressed molecule involved in selection protein 2 antibody抗体THEMIS2 Antibody抗体- ￥440 - 1320
- CUSABIO
- CN
- CSB-PA735984LA01HU
- 2025年07月13日
- ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200
- Rabbit
- Human
企业认证
相关产品推荐更多 >
RIPOR2抗体RIPOR2兔多抗抗体Protein FAM65B antibody抗体RIPOR2 Antibody, FITC conjugated抗体
￥880
CNMD抗体CNMD兔多抗抗体MYETS1 antibody抗体CNMD Antibody, FITC conjugated抗体
￥880
CLOCK抗体CLOCK兔多抗抗体KIAA0334 antibody抗体CLOCK Antibody, HRP conjugated抗体
￥880
TSPAN1抗体TSPAN1兔多抗抗体Tetraspanin TM4-C抗体TSPAN1 Antibody, FITC conjugated抗体
￥880LCE1B抗体LCE1B兔多抗抗体SPRL2A antibody抗体LCE1B Antibody, HRP conjugated抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Protein THEMIS2 protein (62-177AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q5TEJ8
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200
- 浓度：
>95%,Protein G purified
- 靶点：
THEMIS2
- 抗体英文名：
THEMIS2 Antibody
- 抗体名：
Thymocyte-expressed molecule involved in selection protein 2 antibody
- 规格：
100μg/50μg/20μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
| 规格： | 20μg | 产品价格： | ￥440.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
May constitute a control point in macrophage inflammatory response, promoting LPS-induced TNF production.风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identifying Small‐Molecule Modulators of Protein‐Protein Interactions
of Small‐Molecule Inhibitors of In Vivo Protein‐Protein Interactions by Genetic Selection Support Protocol 1: Construction and Optimization of a Strain for Inhibitor Selection Support Protocol 2: Construction
Selection on the Protein-Coding Genome
. Regions of genes where new mutations are beneficial, rather than neutral or deleterious, tend to evolve more rapidly due to positive selection. Genes involved in immunity and defense are a well-known example; rapid evolution in these genes presumably
Expanding the Conformational Selection Paradigm in Protein-Ligand Docking
Conformational selection emerges as a theme in macromolecular interactions. Data validate it as a prevailing mechanism in protein–protein, protein–DNA, protein–RNA, and protein–small molecule drug recognition. This raises the question
技术资料暂无技术资料 索取技术资料
